Literature DB >> 10651624

Influence of a pulmonary surfactant on the in vitro activity of tobramycin against Pseudomonas aeruginosa.

E J Caldwell, D S Piper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10651624      PMCID： PMC89615          DOI： 10.1128/AAC.43.12.3044

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  4 in total

1.  Pulmonary surfactant as a vehicle for intratracheal delivery of technetium sulfur colloid and pentamidine in hamster lungs.

Authors:  V S Kharasch; T D Sweeney; J Fredberg; J Lehr; A I Damokosh; M E Avery; J D Brain
Journal:  Am Rev Respir Dis       Date:  1991-10

2.  Quantitative deposition of aerosolized gentamicin in cystic fibrosis.

Authors:  J S Ilowite; J D Gorvoy; G C Smaldone
Journal:  Am Rev Respir Dis       Date:  1987-12

3.  Influence of pulmonary surfactant on in vitro bactericidal activities of amoxicillin, ceftazidime, and tobramycin.

Authors:  A van 't Veen; J W Mouton; D Gommers; J A Kluytmans; P Dekkers; B Lachmann
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

4.  Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks.

Authors:  S Mukhopadhyay; M Singh; J I Cater; S Ogston; M Franklin; R E Olver
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.